Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Tata

Showing results (211-220 of 272) with videos related to

Pageof 28
Sort By:
Bioorganic & Medicinal Chemistry Letters|August 26, 2015
A novel series of indazole-/indole-based glucagon receptor antagonistsSongnian Lin, Fengqi Zhang, Guoqiang Jiang, et al.
Bioorganic & Medicinal Chemistry Letters|August 6, 2002
Indinavir analogues with blocked metabolism sites as HIV protease inhibitors with improved pharmacological profiles and high potency against PI-resistant viral strainsYuan Cheng, Fengqi Zhang, Thomas A Rano, et al.
Bioorganic & Medicinal Chemistry Letters|February 24, 2009
Synthesis and biological evaluation of platensimycin analogsHong C Shen, Fa-Xiang Ding, Sheo B Singh, et al.
Bioorganic & Medicinal Chemistry Letters|November 28, 2006
Design and synthesis of conformationally constrained tri-substituted ureas as potent antagonists of the human glucagon receptorRui Liang, Lauren Abrardo, Edward J Brady, et al.
Bioorganic & Medicinal Chemistry Letters|July 11, 2003
HIV protease inhibitors with picomolar potency against PI-Resistant HIV-1 by extension of the P3 substituentJoseph L Duffy, Thomas A Rano, Nancy J Kevin, et al.
Bioorganic & Medicinal Chemistry Letters|September 3, 2003
HIV-1 protease inhibitors with picomolar potency against PI-resistant HIV-1 by modification of the P1' substituentJoseph L Duffy, Brian A Kirk, Nancy J Kevin, et al.
Bioorganic & Medicinal Chemistry Letters|August 6, 2002
Synthesis and activity of novel HIV protease inhibitors with improved potency against multiple PI-resistant viral strainsJoseph L Duffy, Nancy J Kevin, Brian A Kirk, et al.
Bioorganic & Medicinal Chemistry Letters|November 1, 2003
Novel HIV-1 protease inhibitors active against multiple PI-resistant viral strains: coadministration with indinavirNancy J Kevin, Joseph L Duffy, Brian A Kirk, et al.
Bioorganic & Medicinal Chemistry|November 1, 2005
Direct observation (NMR) of the efficacy of glucagon receptor antagonists in murine liver expressing the human glucagon receptorSheila M Cohen, Joseph L Duffy, Corin Miller, et al.
Bioorganic & Medicinal Chemistry Letters|August 25, 2009
A strategy of employing aminoheterocycles as amide mimics to identify novel, potent and bioavailable soluble epoxide hydrolase inhibitorsHong C Shen, Fa-Xiang Ding, Qiaolin Deng, et al.
Pageof 28

Showing results (211-220 of 272) with videos related to

Sort By:
Pageof 28
Bioorganic & Medicinal Chemistry Letters|August 26, 2015
A novel series of indazole-/indole-based glucagon receptor antagonistsSongnian Lin, Fengqi Zhang, Guoqiang Jiang, et al.
Bioorganic & Medicinal Chemistry Letters|August 6, 2002
Indinavir analogues with blocked metabolism sites as HIV protease inhibitors with improved pharmacological profiles and high potency against PI-resistant viral strainsYuan Cheng, Fengqi Zhang, Thomas A Rano, et al.
Bioorganic & Medicinal Chemistry Letters|February 24, 2009
Synthesis and biological evaluation of platensimycin analogsHong C Shen, Fa-Xiang Ding, Sheo B Singh, et al.
Bioorganic & Medicinal Chemistry Letters|November 28, 2006
Design and synthesis of conformationally constrained tri-substituted ureas as potent antagonists of the human glucagon receptorRui Liang, Lauren Abrardo, Edward J Brady, et al.
Bioorganic & Medicinal Chemistry Letters|July 11, 2003
HIV protease inhibitors with picomolar potency against PI-Resistant HIV-1 by extension of the P3 substituentJoseph L Duffy, Thomas A Rano, Nancy J Kevin, et al.
Bioorganic & Medicinal Chemistry Letters|September 3, 2003
HIV-1 protease inhibitors with picomolar potency against PI-resistant HIV-1 by modification of the P1' substituentJoseph L Duffy, Brian A Kirk, Nancy J Kevin, et al.
Bioorganic & Medicinal Chemistry Letters|August 6, 2002
Synthesis and activity of novel HIV protease inhibitors with improved potency against multiple PI-resistant viral strainsJoseph L Duffy, Nancy J Kevin, Brian A Kirk, et al.
Bioorganic & Medicinal Chemistry Letters|November 1, 2003
Novel HIV-1 protease inhibitors active against multiple PI-resistant viral strains: coadministration with indinavirNancy J Kevin, Joseph L Duffy, Brian A Kirk, et al.
Bioorganic & Medicinal Chemistry|November 1, 2005
Direct observation (NMR) of the efficacy of glucagon receptor antagonists in murine liver expressing the human glucagon receptorSheila M Cohen, Joseph L Duffy, Corin Miller, et al.
Bioorganic & Medicinal Chemistry Letters|August 25, 2009
A strategy of employing aminoheterocycles as amide mimics to identify novel, potent and bioavailable soluble epoxide hydrolase inhibitorsHong C Shen, Fa-Xiang Ding, Qiaolin Deng, et al.
Pageof 28